The drug is approved for the treatment of suspected or laboratory confirmed incidences of Covid-19 in adults and children hospitalised with severe presentations of the disease, Mylan said in a statement.
from The Financial Express https://ift.tt/3hofxpB
Monday, 20 July 2020
Covid drug: Mylan launches Remdesivir’s generic version in India for coronavirus patients
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment